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Inhalant allergens applied to the skin of sensitive 
atopic dermatitis patients by means of a modified patch 
test technique, induce acute eczematous lesions. These 
lesions contain basophils, eosinophils, mononuclear 
cells, and neutrophils and represent an example of hu-
man cutaneous basophil hypersensitivity. The role of 
IgE antibody in this eczematous reaction was studied by 
systemic and local passive transfer experiments. Plasma 
with high lgE antibody when infused into patients with 
hypogammaglobulinemia as part of their replacement 
treatment resulted, post infusion, in cutaneous mast cell 
and blood basophil sensitization as measured by quan-
titative skin testing and leukocyte histamine release. 
Subsequent patch tests on these patients using the house 
dust mite antigen, antigen P1, produced macroscopic 
erythematous responses containing mononuclear cells, 
and eosinophils but not basophils. Local transfer of 
atopic dermatitis serum with high lgE antibody pro-
duced weak macroscopic responses and in these lesions 
mononuclear cells and both basophils and eosinophils 
were present. The serum activity which allowed trans-
fer of basophil and eosinophil recruitment was heat 
labile. Specifically purified antibody to the mite antigen 
P 1 (containing lgE and lgG antibody), when transferred, 
allowed eosinophil but not basophil recruitment to patch 
test sites. These results suggest that while the allergen-
induced patch test response may involve IgE antibodies, 
as well as the cells normally involved in delayed re-
sponses, another serum activity is also involved. 
The immune mechanisms involved in the pathogenesis of 
atopic dermatitis are unclear. The cellular infiltrate present in 
the chronic lichenified lesions of this disease suggests a fo rm 
of delayed hypersensitivity (DH) reaction [1). On t he other 
hand, individuals with this disease frequently have very high 
levels of lgE antibody and, when skin tested, show wheal-and-
flare responses in 10 min to multiple different allergens [2,3) . 
Proof that the allergens that give rise to immediate responses 
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are a cause of the skin lesions or of the cellular infiltrate of 
this disease is lacking. Recently, however, we have reported 
that aqueous allergen extract applied as a patch test to the 
mildly abraded skin of patients with atopic dermatitis can 
induce an eczematous reaction in 48 h [4). These lesions are 
infiltrated with basophils and eosinophils as well as mononu-
clear cells and neutrophils, and appear to represent a form of 
cutaneous basophil hypersensitivity (CBH) in humans [5,6) . 
Dvorak and Mihm have reported that basophils and sometimes 
eosinophils are present in induced contact hypersensitivity 
lesions in humans [7) . Similarly, basophils have been reported 
to be part of the indurated late-phase reactions that sometimes 
follow immediate hypersensitivity reactions [8-11). It now ap-
pears that CBH may be a common form of human cellular 
immunity [12,13). 
In guinea pigs, CBH is regarded as a form of delayed sensi-
tivity that is distinct from classical DH. Basophils are very rare 
in the cellular infiltrate of classical DH. The ability to dem-
onstrate CBH is lymphocyte-dependent [14) and responsive-
ness can be adoptively transferred with T cells from immune 
animals (15,16]. Under some circumstances, it is also possible 
to transfer CBH reactivity with intravenous injections of im-
mune serum, and the active constituent of the serum appears 
to be IgG 1 antibodies [17) . This class of guinea pig antibodies 
can passively transfer the ability to elicit cutaneous anaphylaxis 
locally. By contrast, it has not proved possible to transfer CBH 
responsiveness with local injections of IgG1 antibodies. This 
suggests that t he elicitation of CBH requires more than simple 
binding of lgG. antibodies to mast cells. Further evidence that 
serum factors regulate basophil accumulation comes from ani-
mals immunized with protein emulsified with complete 
Freund's adjuvant. These animals normally demonstrate DH, 
but when their T cells are transferred, the lesions elicited in 
the recipients represent CBH [16) . However, if both T cells 
and serum from the immune animals are transferred, basophil 
recruitment is suppressed [18) . Thus, the recruitment of baso-
phils into the skin of actively immunized animals is under 
complex regulation. 
Since both CBH in guinea pigs and the late-phase reaction 
in humans can be passively transferred with serum, we won-
dered whether the eczematous delayed response elicited in 
allergic humans could be transferred. We have carried out 
systemic transfer of lgE-rich plasma into immunodeficient 
patients and local transfer of both serum and purified antibod-
ies into nonimmune individuals. These experiments indicated 
that it was possible to transfer either locally with serum or 
systemically with plasma, the ability to elicit delayed erythem-
atous lesions. The responses elicited following passive transfer 
were erythematous but did not have the eczematous features 
that were seen on patients with atopic dermatitis. Following 
either systemic or local transfer the lesions elicited were infil-
trated with eosinophils. In contrast, basophil infiltration oc-
curred with local transfer of immune serum but not with 
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systemic plasma or loca l purified IgE antibody transfer. The 
results suggest that t he inhalant allergen-induced patch re-
sponse in allergic individuals may involve a serum factor as 
well as lgE antibody and the cells norma lly involved in delayed 
responses. 
MATERIALS AND METHODS 
Patients and Plasma 
Seventeen patients with diagnosed atopic dermatitis (age range, 18-
45 years) who had positive immediate skin tests with Dermatophag01:des 
pteronyssinus extract were studied when in remission using a modified 
patch test technique. All had suffered from severe or moderately severe 
skin inflammation which was extensive and involved limbs, trunk, and/ 
or face. Twelve of these patients also suffered from bronchial asthma. 
Five were chosen as plasma and/or serum donors because they were 
group and cross-match compatible with the plasma recipients. Plasma 
obtained using a sterile plasmapheresis procedure (Haemonetics Model 
30 blood processor), was tested for hepatitis B antigen and stored at 
-35°C. Five patients with late-onset primary hypogammaglobulinemia 
consented to be plasma recipients. These patients had normal T-cell 
numbers and markers [19], as well as normal eosinophil and basophil 
counts. In addition, 4 who had been tested showed normal T-cell helper 
function for immunoglobulin production in vitro using pokeweed mi-
togen and co-culture with normal B cells [19]. The patients with 
bypogammaglobulinemia had all received plasma infusion in the past 
as part of their management, and the present infusions were arranged 
to fit into their treatment schedule. Fifteen nonatopic subjects with 
negative immediate skin tests and normal total IgE levels, were also 
studied. Ten of these individuals consented to local transfer studies 
involving the intradermal injection of atopic serum or purified anti-
body. All procedures involving human subjects have been passed by the 
North wick Park Hospital ethical committee and the subjects were fully 
informed about the risks involved. 
Allergens and Skin Testing Techniques 
Antigen P, was purified from an extract of D. pteronyssinus culture 
by concentration over an Amicon PM10 filter, fractionation on Sepha-
dex G-100 and pevicon block electrophoresis [20]. Ragweed extract was 
obtained from Center Laboratories. For patch tests, a 2 X 2 em area of 
skin was gently abraded with a scalpel blade, removing the upper layers 
of the epidermis. The sites included the flexor aspect of the forearm , 
the outer aspect of the upper arm, and the back medial to the scapula. 
Control patch test sites were a lways placed in a comparable position 
on the contralateral side of the body. Allergen diluted to 10 J.ig/ ml in 
normal saline (0.5 ml) was applied on a pad of steri le gauze, occluded 
with plastic, and retained in position using hypoallergenic tape. After 
48 h, the site was inspected, graded, and biopsied under local anesthetic 
using a 4-mm disposable punch biopsy needle. Care was taken to 
infi ltrate anesthetic a round, but not into, the biopsy site. Specimens 
were fixed in Karnovsky's solut ion for 24 h, washed in 4 changes of 0.1 
M sodium cacodylate buffer, pH 7.4, at 4 ·c, and dehydrated in varying 
concentrations of alcohol. Subsequently these biopsy specimens were 
embedded in hydroxyethyl methacrylate and 1- to 2-J.Im sections were 
cut and stained with Giemsa or Azure A [21] . All sections were 
examined at 630X (Zeiss Planapo lens), and infiltrating cells were 
identified and counted in the dermis down to the panniculus adiposus. 
The occasional cells that had migrated into or th rough the epidermis 
were not included. Section lengths were confirmed prior to counting 
and, where necessary, deeper sections were cut to ensure that the 
section represented the total width of the 4 rom-diameter biopsy 
specimen. 
Following plasma infusion, patches were applied after 2 h and 
examined afte r 48 h. After local passive transfer, patches were applied 
at 24 h (i.e., at the normal time for Prausnitz-Kustner [PK] testing). 
Intradermal skin tests were carried out using 0.02 ml of antigen P, at 
concentrations of w-6 J.lg/ ml through 10 J.lg/ ml [22]. Reactions were 
measured at 15 min and a 6 X 6 mm wheal was regarded as a 2+ end 
point. PK testing was carried out by testing the sites with 0.02 ml of 
0.1 J.Lg/ml antigen P, 24 h later. 
Purified Antibodies 
Antibodies to antigen P, were purified using affinity chromatography 
as described previously [20]. Antigen P~, 10 J.lg, was linked to 15 ml of 
cyanogen bromide-activated Sepharose 4B. This immunosorbent was 
washed and packed in a 12 mm x 20 em column. Two hundred 
milliliters of plasma containing high levels of IgE and IgG antibodies 
to antigen P, was passed over the column for 2 h. The column was 
t hen washed and eluted with 0.1 M glycine HCl, pH 2.7. The eluted 
protein was rapidly neutralized with 2.0 M Tris, pH 9.0, and concen-
trated by negative pressure dialysis. 
Antibodies to Antigen P,, Total Serum JgE, and Histamine Release 
Antibodies to antigen P, were measured using class-specific double 
antibody antigen binding assay [23,24] . The results were obtained from 
a control curve and expressed in arbitrary units of binding activity (1 
unit BA- 1 ng). Total serum IgE was measured using double antibody 
inhibition radioimmunoassay and results are given in international 
units (IU) [25]. Histamine release was measured by fluorometric assay 
after 20-min incubation of leukocytes with serial dilutions of antigen 
P, [26]. 
RESULTS 
Eczematous Patch Test Responses to Antigen P1 in Patients 
with Atopic Dermatitis 
In a series of 17 dust mite allergic patients with atopic 
dermatitis, patch tests with the purified dust mite allergen 
antigen P, produced a delayed (48 h) eczematous response(++ 
or +++) in 15 (Table I) . These patch tests required 5 1-Lg allergen 
applied for 48 h to mildly abraded skin, whereas immediate 
wheal-and-flare responses could be produced in these same 
patients with intradermal injections of nanogram or picogram 
quantities of allergen (Table 1) . No delayed phase responses to 
immediate skin testing were recorded. When the patients were 
patch tested with saline, only 1 showed an eczematous response 
(++).Similarly, antigen P, on the skin of nonallergic individ-
uals did not produce a response (0/15) (Table 1). On biopsy, 
the eczematous patch tests were shown to be infiltrated with 
basophils and eosinophils as well as mononuclear cells and 
neutrophils (Table II). Basophils were identified by their mul-
tilobed nuclei, and variable-sized metachromatic granules. Usu-
ally there was evidence of degranulation (4] . In contrast, mast 
cells had a single nucleus and regular, more peripherally dis -
tributed granules. These cells did not increase in number in 48-
h patch test responses. The mononuclear cells present included 
monocytes, lymphocytes, a nd endothelial cells. By contrast 
biopsies from 17 saline patches and 3 ragweed patches on thes~ 
same patients showed ve~y few basophils or eosinophils, and 
markedly fewer neutrophils and mononuclear cells (Table II) . 
TABLE I. Macroscopic skin tests and seru.m antibody Levels in atopic 
dermatitis patients 
Atopic dermatitis Non atopic 
Antigen P, Saline Antigen P, 
(n = 17) (n = 17) (n = 15) 
Patch test +++ 5 0 0 
responses graded ++ 10 1 0 
macroscopically" + 2 5 1 
±or 0 0 11 14 
Intradermal 10-• to 10..,. 17 0 
skin tests w-> to JO- l 0 1 
l' g/ml• > 101 0 14 
Total IgE 5299 39 
IU/ ml (3249- 8642) (24-63) 
Antibodies to lgE 189 3 
antigen P, (98- 364) (3- 4) 
(binding lgG 521 4 
activity)' (1 31-2085) (3- 4) 
• 0 = no reaction; ± = erythema covering< 10% of the patch area; + = patchy 
erythema with occasional papules; ++ = confluent papular erythema with or 
without. a mild exudate; +++ = as ++ but. with exudation edema and extension 
beyo nd the patch area. 
• Using 0.02 ml of serial 10-fold dilutions of antigen P,. A wheal > 6 x 6 mm 
was regarded as the end point. Skin tests negative at 10 JJg/ ml are recorded as> 
101 • 
'The results for lgE and lgG antibodies t.o antigen P, were obtained from a 
contro l curve and expressed in arbitrary units of binding activity (1 unit BA - 1 
ng). Results are expressed as geometric mean values. Figures in parentheses 
represent 95% confidence intervals around the geometric mean. 
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The 3 patients tested with ragweed antigen were previously 
shown not to have immediate hypersensit ivity to this antigen. 
Systemic Passive Transfer into Patients with 
Hypogammaglobulinemia 
Plasma obtained from 5 of the atopic dermatitis patients was 
transfused into 5 group- and cross match-compatible patients 
with primary hypogammaglobulinemia. Each patient received 
3 units of plasma intravenously over a 4-h period; no transfu-
sion reactions were observed. The recipients had very low levels 
of serum lgE prior to infusion and reached levels of 553-3800 
IU/ml (Table III) . Specific antibodies rose in parallel with 
serum lgE (Table III) . Over the 48 h after infusion, total and 
specific lgE in the serum fell by > 50%. In each recipient 
immediate skin reactivity became demonstrable as early as 2 h 
post infusion, maximal at 24 h, and remained constant over the 
next 7 days (Table IV and data not shown). In addition, 4 out 
of 5 recipients gave positive histamine release from peripheral 
blood leukocytes with antigen P 1 at 1 and 48 h after infusion 
(Fig 1). No significant differences were noted between these 
two time points. Patch testing post infusion showed erythem-
atous responses in each of the recipients (Table IV) . However, 
2 of the 5 recipients had shown positive responses prior to 
infusion . These patch responses post infusion were qualita-
tively different from those seen in the plasma donors as they 
showed few papules and had less induration and exudation. 
Microscopically, neither eosinophils nor basophils were pres-
ent in the preinfusion patch test biopsies. Postinfusion, the 
patch test responses in all 5 patients showed pronounced eosin-
TABLE 11. Differential cell count of infiltrating cells in biopsies from 
patch test sites" 
Atopic dermatitis subjects Non-atopic subjects 
Antigen P, Ragweed Saline Antigen P, 
(n = 17) (n = 3) (n = 17) (n = 15) 
Basophil 26 1 1 b o• 
(4-214) (l-8) (0-29) (0-23) 
Eosinophil 104 17 7' 1 b 
(24-1786) (5-24) (0-89) (0-5) 
Mast cell 60 74 56" 68. 
(19- 174) (56-74) (24-144) (23-97) 
Mononuclear 727 304 339' 231 < 
ce ll (368-1254) (296-41 5) (138-658) (115-909) 
Neutrophils 37 14 16d 8' 
(1 2-283) . (8-23) (3-205) (0-62) 
"Histologic sections examined were of similar size (4-mm width). Where 
necessary, further sections were cut to ensure comparability. All infiltrating cells 
in the dermis were counted. Results are expressed as median values and the 
range. Within-subject compari sons between the number of each cell type infil-
trating the lesions induced with antigen P, and saline were made by means of 
the sign test; between-subject comparisons of antigen P1-induced lesions were 
made by means of the Mann-Whitney U- test )27 ). 
b p < 0.0001 . 
' p < 0.0005. 
• Not significant. 
• p < 0.0025. 
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ophil infiltration but basophil infiltration was not present m 
any of these biopsies (Table V). 
Passive Local Transfer into the Skin of Nonallergenic 
Individuals 
Serum was obtained from 3 subjects with atopic dermatitis 
who were known to recruit basophils to an antigen P 1 patch 
test on their own skin. These sera, which gave positive PK 
tests at a dilution >1:2000 were used at 1:2 dilution and 0.05 
ml was injected intradermally into 7 nonatopic control subjects. 
Antigen P1 patch tests were applied to these sites after 24 h 
and examined 48 h later. The patch tests gave negative or 
weakly positive macroscopic erythematous reactions; however, 
on biopsy, a significant infiltrate of both eosinophils and ba-
sophils was present (Table V). The number ofbasophils present 
was comparable to that seen in patch tests on patients with 
atopic dermatitis (Table I) . Three types of controls were used 
for local passive transfer. Use of saline injections followed by 
antigen P1 patch tests did not give rise to basophil or eosinophil 
recruitment. If the serum was heated at 56•C for 2 h prior to 
injection, the subsequent response to antigen P 1 was abolished. 
Furthermore, in two patches after serum transfer, ragweed 
extract was used instead of a ntigen P~, and this did not produce 
a significant basophil or eosinophil infiltrate. 
The results of patch testing following the heating of serum 
might be thought to imply that the activity in serum was 
associated with lgE antibody. However, we had previously seen 
that systemic transfer, which gave rise to marked immediate 
hypersensitivity, did not allow basophil recruitment. In order 
to investigate the role of IgE antibody further, we used specif-
ically purified lgE and lgG antibodies to antigen P 1 for local 
TABLE IV. Skin test responses after passive transfer 
Systemic plasma 
(5) 
Local serum• 
(7) 
Patch tests with antigen P, 
( 10 JJg/ml for 48 h) 
Pre Post 
± ++ 
++ +++ 
Neg + 
Neg + 
+ + 
No heat Heat 
Neg + 
Neg ± 
Neg ± ND 
Neg ± ND 
Neg ± ± 
Neg + ND 
Neg ± ND 
In tradermal sk in tests a 
(JJg/ml at end point) 
Post 
w-2 
w-' 
w-• 
w-s 
w-• 
" Performed using 0.02 ml of serial 10-fold dilutions of antigen P1. A 
wheal > 6 X 6 mm was regarded as the end point. All subjects were 
skin test-negative (both prick and intradermal at 10 llg/ml) prior to 
transfer. ND represents not done. 
b These sera gave positive PK tests at > 1:2000 dilution; 0.05 ml of a 
1:2 dilution was used . 
TABLE III. Antibody Levels (pre and post plasma infusion)" 
Total lgE antibody Specific antibody (BA/ml) (IU/ml) 
Plasma lgE anti-P, l gG nnti-P1 
recipients Post Post Donor Pre infusion infusion Post Post Post plasma infusion (1h) (48h) Donor infusion infusion Donor infus io n plasma Plasma (1 h) (48 h) (1 h) 
1 11,600' 10 3,800 1,650 564 51 20 141 49 
2 6,400 42 553 233 103 41 18 165 36 
3 9,900 ' 9 1,835 808 281 28 8 216 18 
4 8,900 6 837 425 196 54 24 225 29 
5 7,300' 4 2,101 1,222 768 200 133 2,962 485 
• Tota l lgE levels and specific P, antibodies of both IgG and lgE isotypes were measured before and at 1 and 48 h after infusion. 
b Sera from these 3 atopic dermatitis patients were also used in local transfer experiments. 
Post 
infusion 
(48 h) 
38 
22 
9 
21 
334 
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t ransfer (IgE ab: 10,4 79 BA uni ts/ml; IgG ab: 8,254 BA units/ 
ml). Five nonatopic control subjects received 0.05 ml of antigen 
P 1 -specific antibody intradermally at 4 different sites. After 24 
h immediate wheal responses (> 6 X 6 mm) using 10-" to 10- • 
J.Lg/ml antigen P,/ml were elicited at 3 of these sites. Thus, 
mast cell sensitization with IgE antibody was comparable to 
that seen in the patients. Patch testing with antigen P, (5 J.Lg) 
at the remaining site, 24 h after injection, resulted in positive 
erythematous macroscopic responses 48 h later (Table IV) . 
When these lesions were biopsied, they were found to have a 
s ignificant eosinophil infiltrate; however, there was no basophil 
infiltrate (Table V) . In Table V the mononuclear cell counts 
100 
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Q) 
c: 
'f§ 10 ro 
-
(/) 
.c 5 
ro 
-0 
-
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No 10- 8 w-6 10-4 w-2 
Antigen AgP 1 (l..lg/m I) 
FIG 1. Leukocyte histamine re lease 48 h after plasma infusion. 
% Total histamine release= 
(Histamine released by antigen P, stimulation 
- Background release of histamine) x 100 
Histamine released by incubation at lOO"C 
Each symbol represents 1 patient. Preinfusion of all 5 subjects showed 
< 5% histamine release. 
are also shown. These reveal a higher number of mononuclear 
cells in patches after systemic and local transfer. However, in 
general, there was greater background variability with both 
mononuclear cells and neutrophils than with eosinophils and 
basophils. 
DISCUSSION 
Using either systemic plasma infusion , local serum, or local 
purified antibody, it has proved possible to transfer the ability 
to elicit immediate and "delayed in time" reactions of the skin. 
Immediate hypersensitivity was demonstrable by intradermal 
skin testing, and also after systemic t ransfer, by the demon-
stration of histamine release from peripheral blood leukocytes. 
The delayed skin lesions demonstrated on t he plasma recipients 
after 48-h patch tests were erythematous, and in several cases, 
this erythema was as intense as t hat seen in patches on the 
donors. The macroscopic reactions to patch testing following 
local serum or antibody transfer were generally very weak. 
Although we elicited delayed erythematous reactions following 
transfer, these reactions lacked the other macroscopic features 
of eczema. Thus, it has not proved possible to passively transfer 
the full lesion that can be demonstrated on patients with atopic 
dermatitis. 
The biopsies from antigen P, patches on patients with atopic 
dermatitis, have the features of CBH, with basophils, eosino-
phils, and mononuclear cells infiltrating the dermis. Following 
both systemic and local transfer, the presence of an eosinophil 
infiltrate in the antigen P, patch tests correlated closely with 
the transfer of immediate hypersensitivity. Thus, the eosinophil 
infiltrate may be explained simply by the release of mediators 
from passively sensitized mast cells in the skin. The modest 
increases in mononuclear cells and neutrophils may also be 
explained on this basis. In the transfer experiments, basophil 
recruitment was seen only after local transfer of unheated 
serum. The failure of systemic transfer or local antibody to 
recruit basophils suggests strongly that sensitization of mast 
cells with lgE antibody is not sufficient on its own to recruit 
basophils. This finding is in keeping with the fact that basophils 
are not present in skin lesions induced by histamine injection 
or 48/80-induced mast cell degranulation [28). Also, mediators 
re leased from mast cells and basophils have not been demon-
strated to have basophil chemotactic activity. While it i~ clear 
that basophils are present in late-phase skin responses, it is 
TABLE V. Cells infiltrating patch test sites following passive transfer 
Differential ce ll count on biopsy section (mag x 630)" 
Transfer No. Antigen used Mononuclear in patch test Basophil Eosinophil Mast. cell 
ce ll Neutrophil 
Systemic 
Antigen P, 0 1 61 296 16 Preplasma 5 (0- 1) (0-5) (20- 86) (164 - 665) (2- 254) 
Post plasma 5 Antigen P, 1 145 47 339 47 (0-4) (3-535) (32- 93) (162- 797) (25- 409) 
Local 
1 44 206 Saline 8 Antigen P, 0 6 (0- 4) (0- 2) (23- 92) (129- 263) (0- 31) 
Seru m 7 Antigen P, 69b 320. 82' 415' 59' ( 12- 161) (20-560) (46-87) (165- 74 1) (3- 200) 
2 Ragweedd (2- 4) (4 - 30) (80- 113) (264 - 54 1) (11- 27) 
Heated serum ' 3 Antigen P, 6 0 63 327 2 (0-6) (0- 10) (29-108) (106- 347) (2-56) 
Purified .5 Antigen P, 0 99 34 347 19 
antibody (0-7) (45- 188) (21-41) (237- 606) (13- 50) 
Statistical ana lysis between the number of each cell type infiltrati ng the lesions ind~ced with antigen P, and saline following local serum 
transfer was made usi ng the sign test. No significant testing was dor:e on groups compnsmg 5 ?r fewer subJects. 
a Histologic sections were of similar size (4-mm width) and all mhltratmg cells m the dermts were counted. Results are expressed as median 
values and the range. 
•p < 0.016. 
' Not significant. 
d Ragweed extract was obtained from Greer Laboratories Inc. Lenoir, North Carolina. 
• Serum was heated at 56"C for 3 h. 
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not clearly shown that basophils are recruited to the delayed 
cutaneous reactions that can be elicited following transfer of 
IgE antibody [8) . In the present experiments, the ability of 
immune serum to mediate basophil recruitment was abolished 
by heating. However, it is possible that basophil recruitment 
requires IgE antibody-induced mediator release and another 
factor. Our findings contrast with results in guinea pigs where 
recruitment of basophils to a skin site has been seen after 
systemic transfer but not after local transfer [17). We estimate 
that the quantity of plasma that we used for systemic transfer 
was 6-fold greater on a weight:volume ratio than the minimum 
quantity of immune serum necessary for systemic transfer of 
CBH to a guinea pig. We consider it unlikely that the differ-
ences between systemic and local transfers were due to the use 
of plasma in one case and serum in the other. Also the difference 
in the time of application of patch tests following the respective 
procedures was unlikely to explain the absence of basophil 
recruitment in the case of systemic transfer. 
The mechanism for basophil recruitment and accumulation 
in hypersensitivity lesions is unknown. In experimental ani-
mals, basophil recruitment is T cell-dependent. Even when 
serum is used to transfer CBH, T cells in the recipient may 
play an active role [6) . In humans, the only established basophil 
chemotactic factors are lymphocyte-derived chemotactic factor 
(LDCF) and the activated complement component C5a 
[29,30]. Recently, we have found that peripheral blood baso-
phils from patients with atopic dermatitis will respond to both 
these agents in vitro (31] . It is possible that immune serum 
contains a factor that can mediate basophil recruitment. This 
factor could act cytophilically to release a basophil chemotactic 
factor from a secondary cell or might be involved in the recruit-
ment ofT cells which were in turn induced to release LDCF. 
If t here is a serum factor responsible for basophil recruitment, 
t hen we have to assume that this factor does not accumulate 
in the skin following systemic transfer of plasma. Whether it 
is possible that this lack of accumulation is due to the putative 
factor having a large molecular size and thus not entering the 
tissues has not been determined. It is also possible that IgG 
antibody with or without complement activation contributed 
to the cell infiltrates observed. Certainly, IgG antibody to 
antigen P 1 was present in all the transfer situations. It seems 
unlikely that IgG antibody contributed to basophil accumula-
tion since this activity was heat-labile and was not mediated 
by the purified antibody which contains high levels of lgG 
antibody. However, in guinea pigs low-affinity lgG ant ibody 
can transfer basophil accumulation , and our specific antibody 
preparations may not fully reflect the affinities of the IgG 
antibody in the whole serum. Also, it has been reported that a 
large proportion of IgG antibody to allergens is of the IgG. 
subclass and would not be expected to fix complement (32] . At 
the present time it remains unclear whether an lgG subclass 
antibody, a serum factor, possibly antigen-specific, or other 
serum component mediates the basophil recruitment that oc-
curs at the patch test sites. 
The presence of basophils in allergen-induced patch test 
reactions on patients with atopic dermatitis suggests that these 
lesions represent a form of DH. However, our results with local 
injections of serum suggest that the sera of these patients 
contain an antigen-specific activity t hat can regulate basophil 
accumulation and does not appear to be lgE antibody. The role 
of the basophils in patch test responses remains unclear. It is 
possible that mediators released locally by basophils have the 
capacity to augment the inflammatory response as has been 
demonstrated in guinea pigs (33,34]. In addition, mediators, 
such as histamine, are known to have immunoregulatory func-
tions which may be involved in the patch test reactions [35]. 
The lesions produced by patch testing after passive transfer 
were not equivalent to the lesions seen on patients with atopic 
dermatitis. Fibrin deposition, seen in delayed reactions [36), 
was present under electron microscopy in some of the patch 
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test responses elicited in atopic dermatitis patients and was 
particularly marked in those showing strong reactions with 
high numbers of basophils present. No consistent pattern of 
fibrin deposition was noted in the patch tests following passive 
transfer. We believe that sensitized T cells may play a role in 
the patch tests on patients with atopic dermatitis. It is well 
established that there is a T-cell infiltrate in atopic eczema, 
and the patch tests on patients had a significant mononuclear 
infiltrate. Furthermore, we have recently proved that T cells 
from these patients will proliferate in vitro in response to 
antigen P1 [37). 
The cell infiltrate in the patch reaction is not the same as 
that reported in chronic lichenified eczema [38] . Recently, we 
have observed that repeated application of antigen for up to 10 
days on patients with atopic dermatitis will produce eczematous 
lesions which more closely represent the histologic picture of 
chronic eczema. In these lesions, eosinophil infiltration is less 
and mast cell hyperplasia replaces basophil infiltration . Mast 
cell hyperplasia replacing early basophil recruitment has been 
demonstrated in other forms of basophil hypersensitivity in 
humans (39). Whether the increased mast cell number that 
occurs in the skin represents a heterogeneous population of 
mast cells remains unclear. In experimental animals, hyperpla-
sia of mucosal mast cells and of cloned mast cells has been 
shown to beT cell -mediated [40,41) . It appears that basophil 
arrival at delayed reactions is under complex control and the 
role of mast cells and basophils in these lesions may be com-
plementary. Taken together our results suggest that the devel-
opment of an eczematous reaction on the skin may well involve 
eosinophils, basophils, IgE antibody, and other serum factors 
as well as a role for specifically sensitized T cells. The present 
experiments may well shed further light on the mechanisms of 
inflammation in naturally occurring atopic dermatitis. 
We wish to thankS. S. Jouhal and Alison Cox for exce llent technical 
assistance, Ann Leversha for skilled secretarial help, and Dr. Leona 
Bassein for statistical analysis. 
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